Skip to main content
. 2018 Jan 1;27(1):10–22. doi: 10.1089/scd.2017.0132

FIG. 3.

FIG. 3.

Flow cytometry-based analysis of hiPSC-derived ECs and the EC controls. (A) Representative histograms showing the positivity for the cell surface markers CD31, CD144, CD34, KDR, and LDL in ECs derived from hiPSCs-PB, hiPSC-HU, and hiPSC-HS complemented with HUVECs and HSVECs. (B) Percentage of cells positive for each endothelial marker. The mean value was calculated from at least three independent differentiations of each hiPSC line (±SEM). The asterisk indicates a statistically significant (P < 0.05) difference in percentage of positive hiPSCs-derived ECs compared with their EC counterparts, as detected using Student's t-test. hiPSC-HS, HSVEC-derived hiPSCs; hiPSC-HU, HUVEC-derived hiPSCs; HSVECs, human saphenous vein endothelial cells; HUVECs, human umbilical vein endothelial cells; KDR, kinase insert domain receptor; LDL, low-density lipoprotein; SEM, standard error of the mean.